Ausgabe 3/2024
Inhalt (11 Artikel)
Prostate cancer and elective nodal radiation therapy for cN0 and pN0—a never ending story?
S. A. Koerber, S. Höcht, D. Aebersold, C. Albrecht, D. Boehmer, U. Ganswindt, N.-S. Schmidt-Hegemann, T. Hölscher, A.-C. Mueller, P. Niehoff, J. C. Peeken, M. Pinkawa, B. Polat, S. K. B. Spohn, F. Wolf, C. Zamboglou, D. Zips, T. Wiegel
Assessing the toxicity after moderately hypofractionated prostate and whole pelvis radiotherapy compared to conventional fractionation
Matthias Moll, Gregor Goldner
Noninvasive inter- and intrafractional motion control in ultrahypofractionated radiation therapy of prostate cancer using RayPilot HypoCath™—a substitute for gold fiducial-based IGRT?
Johannes Berchtold, Carmen Winkler, Josef Karner, Michael Groher, Christoph Gaisberger, Felix Sedlmayer, Frank Wolf
Whole-pelvic irradiation with boost to involved nodes and prostate in node-positive prostate cancer—long-term data from the prospective PLATIN-2 trial
C. A. Fink, D. Wegener, L. D. Sauer, C. Jäkel, D. Zips, J. Debus, K. Herfarth, S. A. Koerber
Comprehensive geriatric assessment predicts radiation-induced acute toxicity in prostate cancer patients
Katarzyna Paal, Bettina Stranz, Eva-Maria Thurner, Uwe Langsenlehner, Wilfried Renner, Thomas Baptist Brunner, Tanja Langsenlehner
Effect of simultaneous integrated boost concepts on photoneutron and distant out-of-field doses in VMAT for prostate cancer
Benjamin Gauter-Fleckenstein, Sebastian Schönig, Lena Mertens, Hans Oppitz, Kerstin Siebenlist, Michael Ehmann, Jens Fleckenstein
Stereotactic body radiotherapy (SBRT) re-irradiation for local failures following radical prostatectomy and post-operative radiotherapy
Wojciech Majewski, Marcin Miszczyk, Donata Graupner, Bartłomiej Goc, Gregor Goldner, Aleksandra Napieralska
Stereotactic body radiotherapy (SIB-VMAT technique) to dominant intraprostatic lesion (DIL) for localized prostate cancer: a dose-escalation trial (DESTROY-4).
Francesco Deodato, Milena Ferro, Paolo Bonome, Donato Pezzulla, Carmela Romano, Milly Buwenge, Savino Cilla, Alessio Giuseppe Morganti, Gabriella Macchia
Fünfzehn-Jahres Ergebnisse nach Monitoring, Operation oder Strahlentherapie aufgrund eines Prostatakarzinoms
Simon K. B. Spohn, Anca-Ligia Grosu
Prophylaktische Strahlentherapie bei asymptomatischen Hochrisiko-Knochenmetastasen
Manuel Guhlich, Stefan Rieken